Skip to main content

Table 3 Odds ratios (OR) and 95% confidence interval (CI) for predicting G2-G3 ccRCC and stage II–III ccRCC

From: KAT3B-p300 and H3AcK18/H3AcK14 levels are prognostic markers for kidney ccRCC tumor aggressiveness and target of KAT inhibitor CPTH2

 

Risk of G2-G3 ccRCC

Risk of stage II–III ccRCC

OR

95% CI

p

OR

95% CI

p

Age

0.994

0.926–1.068

0.875

1.054

0.998–1.113

0.062

p300t

1.076

1.029–1.126

0.001

1.003

0.973–1.034

0.851

H3AcK18

1.021

0.987–1.056

0.223

0.981

0.954–1.008

0.170

H3AcK14

0.971

0.943–0.999

0.041

0.975

0.953–0.999

0.041

Back to article page

Clinical Epigenetics

ISSN: 1868-7083

Contact us